395 related articles for article (PubMed ID: 8016855)
21. Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity.
Yoshizawa S; Matsushima R; Watanabe MF; Harada K; Ichihara A; Carmichael WW; Fujiki H
J Cancer Res Clin Oncol; 1990; 116(6):609-14. PubMed ID: 2174896
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.
Resjö S; Oknianska A; Zolnierowicz S; Manganiello V; Degerman E
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):839-45. PubMed ID: 10417351
[TBL] [Abstract][Full Text] [Related]
23. Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein.
Kloeker S; Reed R; McConnell JL; Chang D; Tran K; Westphal RS; Law BK; Colbran RJ; Kamoun M; Campbell KS; Wadzinski BE
Protein Expr Purif; 2003 Sep; 31(1):19-33. PubMed ID: 12963337
[TBL] [Abstract][Full Text] [Related]
24. Characterization of serine/threonine protein phosphatases in RINm5F insulinoma cells.
Sjöholm A; Honkanen RE; Berggren PO
Biosci Rep; 1993 Dec; 13(6):349-58. PubMed ID: 8204804
[TBL] [Abstract][Full Text] [Related]
25. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.
Fujiki H; Suganuma M
Adv Cancer Res; 1993; 61():143-94. PubMed ID: 8394044
[No Abstract] [Full Text] [Related]
26. Effect of inhibitors of protein phosphatase 1 and 2A on erythroid colony formation: an investigation of the specificities of inhibitors.
Zhang W; Tamura J; Sakuraya M; Naruse T; Kubota K
J Int Med Res; 2001; 29(2):114-8. PubMed ID: 11393344
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine-272 is involved in the inhibition of protein phosphatase-1 by multiple toxins.
Zhang L; Zhang Z; Long F; Lee EY
Biochemistry; 1996 Feb; 35(5):1606-11. PubMed ID: 8634292
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of an archaeal protein phosphatase activity by okadaic acid, microcystin-LR, or calyculin A.
Oxenrider KA; Rasche ME; Thorsteinsson MV; Kennelly PJ
FEBS Lett; 1993 Oct; 331(3):291-5. PubMed ID: 8397116
[TBL] [Abstract][Full Text] [Related]
29. Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways.
Chatfield K; Eastman A
Biochem Biophys Res Commun; 2004 Oct; 323(4):1313-20. PubMed ID: 15451440
[TBL] [Abstract][Full Text] [Related]
30. Use of a colorimetric protein phosphatase inhibition assay and enzyme linked immunosorbent assay for the study of microcystins and nodularins.
An J; Carmichael WW
Toxicon; 1994 Dec; 32(12):1495-507. PubMed ID: 7725318
[TBL] [Abstract][Full Text] [Related]
31. [Naturally occurring toxins with specific inhibitory activity against protein serine/threonine phosphatases 1 and 2A].
Takai A
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1091-101. PubMed ID: 9655967
[No Abstract] [Full Text] [Related]
32. In vitro and in vivo effects of protein phosphatase inhibitors, microcystins and nodularin, on mouse skin and fibroblasts.
Matsushima R; Yoshizawa S; Watanabe MF; Harada K; Furusawa M; Carmichael WW; Fujiki H
Biochem Biophys Res Commun; 1990 Sep; 171(2):867-74. PubMed ID: 2169738
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms underlying inhibition of protein phosphatases by marine toxins.
Dawson JF; Holmes CF
Front Biosci; 1999 Oct; 4():D646-58. PubMed ID: 10502549
[TBL] [Abstract][Full Text] [Related]
34. A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A.
Gupta V; Ogawa AK; Du X; Houk KN; Armstrong RW
J Med Chem; 1997 Sep; 40(20):3199-206. PubMed ID: 9379439
[TBL] [Abstract][Full Text] [Related]
35. Sucrose-phosphate synthase is dephosphorylated by protein phosphatase 2A in spinach leaves. Evidence from the effects of okadaic acid and microcystin.
Siegl G; MacKintosh C; Stitt M
FEBS Lett; 1990 Sep; 270(1-2):198-202. PubMed ID: 2171989
[TBL] [Abstract][Full Text] [Related]
36. Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors.
Fladmark KE; Brustugun OT; Hovland R; Boe R; Gjertsen BT; Zhivotovsky B; Døskeland SO
Cell Death Differ; 1999 Nov; 6(11):1099-108. PubMed ID: 10578179
[TBL] [Abstract][Full Text] [Related]
37. Characterization of protein serine/threonine phosphatase activities in human lung mast cells and basophils.
Peirce MJ; Munday MR; Peachell PT
Br J Pharmacol; 1998 Nov; 125(5):1095-101. PubMed ID: 9846650
[TBL] [Abstract][Full Text] [Related]
38. Molecular enzymology underlying regulation of protein phosphatase-1 by natural toxins.
Holmes CF; Maynes JT; Perreault KR; Dawson JF; James MN
Curr Med Chem; 2002 Nov; 9(22):1981-9. PubMed ID: 12369866
[TBL] [Abstract][Full Text] [Related]
39. [Tumor promotion by inhibitors of protein phosphatase 1 and 2A].
Suganuma M; Fujiki H
Tanpakushitsu Kakusan Koso; 1998 Jun; 43(8 Suppl):1102-10. PubMed ID: 9655968
[No Abstract] [Full Text] [Related]
40. Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle.
Gong MC; Cohen P; Kitazawa T; Ikebe M; Masuo M; Somlyo AP; Somlyo AV
J Biol Chem; 1992 Jul; 267(21):14662-8. PubMed ID: 1321813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
